135 related articles for article (PubMed ID: 10858355)
1. Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations.
Hershberger E; Coyle EA; Kaatz GW; Zervos MJ; Rybak MJ
Antimicrob Agents Chemother; 2000 Jul; 44(7):1921-4. PubMed ID: 10858355
[TBL] [Abstract][Full Text] [Related]
2. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
Vazquez J; Perri MB; Thal LA; Donabedian SA; Zervos MJ
J Antimicrob Chemother; 1993 Nov; 32(5):715-21. PubMed ID: 8125836
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1999 Jan; 43(1):77-84. PubMed ID: 9869569
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Aeschlimann JR; Houlihan HH; Mercier RC; Rybak MJ
Antimicrob Agents Chemother; 1998 Feb; 42(2):254-6. PubMed ID: 9527768
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.
Kim YS; Liu Q; Chow LL; Chambers HF; Täuber MG
Antimicrob Agents Chemother; 1998 Dec; 42(12):3325-7. PubMed ID: 9835540
[TBL] [Abstract][Full Text] [Related]
6. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Maserati R; Cagni AE; Segú C
Chemotherapy; 1996; 42(2):133-9. PubMed ID: 8697888
[TBL] [Abstract][Full Text] [Related]
7. CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Lamp KC; Bailey EM; Rybak MJ
Antimicrob Agents Chemother; 1992 Jun; 36(6):1192-7. PubMed ID: 1329613
[TBL] [Abstract][Full Text] [Related]
8. Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin.
Zaman MM; Landman D; Burney S; Quale JM
J Antimicrob Chemother; 1996 Jan; 37(1):127-32. PubMed ID: 8647753
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections.
Endtz HP; Mouton JW; den Hollander JG; van den Braak N; Verbrugh HA
Antimicrob Agents Chemother; 1997 May; 41(5):1146-9. PubMed ID: 9145886
[TBL] [Abstract][Full Text] [Related]
10. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
Bayer AS; Li C; Ing M
Antimicrob Agents Chemother; 1998 Jul; 42(7):1837-41. PubMed ID: 9661030
[TBL] [Abstract][Full Text] [Related]
12. Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.
Piper KE; Rouse MS; Ronningen KL; Steckelberg JM; Wilson WR; Patel R
Antimicrob Agents Chemother; 2000 Sep; 44(9):2554-6. PubMed ID: 10952616
[TBL] [Abstract][Full Text] [Related]
13. Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus-induced endocarditis.
Mercier RC; Dietz RM; Mazzola JL; Bayer AS; Yeaman MR
Antimicrob Agents Chemother; 2004 Jul; 48(7):2551-7. PubMed ID: 15215108
[TBL] [Abstract][Full Text] [Related]
14. Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin.
Eckart RE; Hospenthal DR; Fishbain JT
Pharmacotherapy; 2000 May; 20(5):589-92. PubMed ID: 10809347
[TBL] [Abstract][Full Text] [Related]
15. Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.
Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1988 Feb; 32(2):262-4. PubMed ID: 3163241
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Barriere SL; Albrecht LM; Rybak MJ
Antimicrob Agents Chemother; 1989 Apr; 33(4):519-21. PubMed ID: 2499251
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin.
Cohen MA; Huband MD; Gage JW; Yoder SL; Roland GE; Gracheck SJ
J Antimicrob Chemother; 1997 Aug; 40(2):205-11. PubMed ID: 9301985
[TBL] [Abstract][Full Text] [Related]
19. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1997 Aug; 41(8):1662-7. PubMed ID: 9257737
[TBL] [Abstract][Full Text] [Related]
20. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]